India Glioblastoma Multiforme Treatment Market Size & Outlook, 2030

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.

In India, the incidence of CNS tumors ranges from 5 to 10 per 100,000 population and accounts for 2% of all malignant cases. The incidence is growing, as per a hospital-based survey. The analysis of one year of registered CNS malignancies shows 38.7% cases of astrocytomas and 59.5% cases of high-grade gliomas.

There is no cure for the condition and the current treatment approaches are limited to improving the overall survival period of patients and relieving pain & symptoms to further improve the quality of life. The treatment of GBM is surgery in eligible patients, followed by radiation and chemotherapy. The Indian healthcare system comprises public and private sectors.

Public healthcare services vary drastically between urban and rural areas. In urban areas, public healthcare comprises few secondary and tertiary care, however, it is mostly limited to basic healthcare facilities in rural areas. Such a scenario increases the treatment burden on patients.

Reasons to subscribe to India glioblastoma multiforme treatment market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India glioblastoma multiforme treatment market databook

Our clientele includes a mix of glioblastoma multiforme treatment market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India glioblastoma multiforme treatment market , including forecasts for subscribers. This country databook contains high-level insights into India glioblastoma multiforme treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list